Navigation Links
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Date:3/31/2008

m" target="_new">http://www.tgrd.com.


'/>"/>
SOURCE Takeda Global Research & Development Center, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
2. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
3. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
4. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
5. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
6. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
7. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
8. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
9. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
10. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
11. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Nov. 25 ERT (Nasdaq: E...y, the Company,s President and CEO, and Keith Schn...O, are scheduled to present at the 21st Annual Pip...n December 1, 2009 in New York City, New York. ,...by visiting the Company,s corporate website at ht...
(Date:11/25/2009)...25 BioTrends Research Group, Inc. ...lara report, the first in a multi-phase syndicat...Centocor Ortho-Biotech,s Stelara, from product lau... Each wave of the report provides quantitative inf...tive information from a subset of 20. The reports...
(Date:11/25/2009)... Fla., Nov. 25 For many ...ecially the 27 million living with untreated hear... says audiologist Cindy Beyer. ,, Dr. Beyer, se...of America,s largest hearing care and hearing aid...s to stress, frustration, and social isolation, "w...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3reThinking eHealth Webinar Announced eHealth Experience Officer Needed Will a New Hospital Executive Emerge as Health Care Reforms 3F 55652 1reThinking eHealth Webinar Announced eHealth Experience Officer Needed Will a New Hospital Executive Emerge as Health Care Reforms 3F 55652 2Alcohol Ads on Cable TV Reach Young Audiences 55648 1Alcohol Ads on Cable TV Reach Young Audiences 55648 2Alcohol Ads on Cable TV Reach Young Audiences 55648 3First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 1First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 2First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 3First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 4
...ntal Research Meeting, DURHAM, N.C., April 7, 200...pment-stage pharmaceutical company dedicated to,tr...body,s mucosal,defenses, today announced prelimina... a novel sodium channel blocker, P-552-02, as a to...y Sjogren,s syndrome. The,preliminary results of t...
...ls (Nasdaq: VIAP ), a biotechnology company focus...nt of cardiovascular disease,announced today that ...),for its VIA-2291 Phase 2 clinical trial program ...ent Phase 2 studies. The DSMB observed a,continued...nded VIA,continue its ongoing trials as planned., ...
Other Medicine Technology:Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4
(Date:11/27/2009)... XenaCare Holdings has announced that it ...ndation, one of the largest nonprofit organization...h education. , Delray Bea...ngs, Inc. (OTCBB: XCHO), a company specializing in... healthcare products, has announced today that is ...
(Date:11/27/2009)... Voyant Health™ announced today tha...ensed its TraumaCad Enterprise orthopedic templati...tion. , (PRWEB) November ...hat Spectrum Health (Grand Rapids, Michigan) has l...ting solution and its TraumaCad Extend workflow so...
(Date:11/26/2009)...YORK, Nov. 27 With cold and flu se...loy good practices to control the spread of infect...tive not only to keep ourselves healthy, but to av...en Finerty, RN, MS, CIC (certified in infection-co... occupational health at Hospital for Special Surge...
(Date:11/26/2009)...oo big or too heavy can lead to strains or worse ,... There may be nothing wrong with stuffing your tur... the same thing with your suitcase as you pack for...treated in 2008 in U.S. hospital emergency rooms, ...ties for luggage-related injuries, such as muscle ...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a l...lina, today announced the expansion of its service...tist, Dr. Doug Macmillan. , ...al is pleased to announce that Dr. Doug Macmillan,...leted an additional advanced training seminar. RT...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...th autism were roughly twice as likely to have bee...zophrenia, than parents of other children, accordi...cords by a University of North Carolina at Chapel ...ffspring, appears in the May 5, 2008, issue of the...
...e-FirstCall/ -- China Sky One,Medical, Inc. ("Chin...,Board: CSKI), a leading fully integrated pharmace...drugs in the People,s Republic of China,("PRC"), t...ompany Limited ("First"), a wholly-owned,subsidiar...
...ing waist line, weight gain and a tendency to deve... a study published today in the journal Nature Gen...ence is significantly more common in those with In...cientists from Imperial College London and other i...
...at 2008 Annual Meeting in San,Diego, CA, NEW YORK..., is the new President of the American Society for...Society, with nearly 2,400,members, is the leading...d on May 4, during the ASAPS 2008 Annual,Meeting i...
...assumptions, children are more vulnerable to the h...an they are in early childhood, according to a Cin... be presented May 4 at the annual meeting of the P... pediatricians should be just as, if not more conc...
...ion costs, BROOKLYN, N.Y., May 3 Thirty-five wom... early Mother,s Day today by building,affordable h...wn these,homes in the future., Sponsored by Habit...a low-income neighborhood and honor mothers,everyw...
Other Medicine News:Health News:Mental disorders in parents linked to autism in children 2Health News:China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits 2Health News:China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits 3Health News:Gene sequence that can make half of us fatter is discovered 2Health News:Long Island Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 2Health News:Long Island Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 3Health News:Children more vulnerable to harmful effects of lead 2Health News:Women Volunteers Celebrate Mother's Day Early by Building Affordable Homes for New York City Families 2
Clinac 2100 C/D Family
MULTI-LINK OTW ULTRA Coronary Stent System
MULTI-LINK OTW ZETA Coronary Stent System
Express Coronary Stent System
Medicine Products: